A recent publication at the KIR addressed the use of artificial intelligence in nephrology. The authors designed an algorithm aimed at early intensification of rituximab regimen in patients at high estimated risk of underdosing to increase the likelihood of remission. They predict the risk of underdosing based on patients’ characteristics. 

Check the full publication at https://www.kireports.org/article/S2468-0249(23)01563-2/fulltext

or watch the π—œπ—¦π—‘ π—©π—œπ——π—˜π—’ 𝗔𝗕𝗦𝗧π—₯𝗔𝗖𝗧 π—¦π—˜π—₯π—œπ—˜π—¦: Optimization of Rituximab Therapy in Adult patients with PLA2R1-associated Membranous Nephropathy with Artificial Intelligence at 

https://x.com/isnkidneycare/status/1759457828954132542?s=46&t=ZrHBe4wvXNR23AIl4lTaPQ 

Do you have other insights on how AI can help nephrology? Post here...